Intestinal stem cells and the development of colorectal neoplasia

Tissue Stem Cells

Volumn , Issue , 2006, Pages 229-270

  McDonald, Stuart A C ^a,b   Graham, Trevor ^c   Potten, Christopher S ^d   Wright, Nicholas A ^b   Tomlinson, Ian P M ^c   Renehan, Andrew G ^e  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248653086     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (255)

1. Potten CS. Intestinal Stem Cells. London: Academic Press, 1997.
2. Wright NA. Stem cell repertoire in the intestine. In: Potten CS, ed. Stem Cells. London: Academic Press, 1997:315-330.
3. Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 2003; 17(14):1709-1713.
4. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2(9):533-543.
5. Bach SP, Renehan AG, Potten CS. Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis 2000; 21(3):469-476.
6. Booth C, Potten CS. Gut instincts: thoughts on intestinal epithelial stem cells. J Clin Invest 2000; 105(11):1493-1499.
7. Brittan M, Wright NA. Gastrointestinal stem cells. J Pathol 2002; 197(4):492-509.
8. Potten CS, Booth C, Pritchard DM. The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol 1997; 78(4):219-243.
9. Potten CS. Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci 1998; 353(1370):821-830.
10. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990; 110(4):1001-1020.
11. Wright NA. Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer. Int J Exp Pathol 2000; 81(2):117-143.
12. Renehan AG, Potten CS. Stem cells and cancer. In: Schwab M, ed. Encyclopaedia of Cancer. Berlin: Springer, 2001:846-853.
13. Preston SL, Alison MR, Forbes SJ, Direkze NC, Poulsom R, Wright NA. The new stem cell biology: something for everyone. Mol Pathol 2003; 56(2):86-96.
14. Renehan AG, O’Dwyer ST, Haboubi NJ, Potten CS. Early cellular events in colorectal carcinogenesis. Colorectal Dis 2002; 4(2):76-89.
15. Marshman E, Booth C, Potten CS. The intestinal epithelial stem cell. Bioessays 2002; 24(1):91-98.
16. Leedham SJ, Brittan M, McDonald SA, Wright NA. Intestinal stem cells. J Cell Mol Med 2005; 9(1):11-24.
17. Clatworthy JP, Subramanian V. Stem cells and the regulation of proliferation, differentiation and patterning in the intestinal epithelium: emerging insights from gene expression patterns, transgenic and gene ablation studies. Mech Dev 2001; 101(1-2):3-9.
18. de Santa Barbara P, van den Brink GR, Roberts DJ. Development and differentiation of the intestinal epithelium. Cell Mol Life Sci 2003; 60(7):1322-1332.
19. Sancho E, Batlle E, Clevers H. Live and let die in the intestinal epithelium. Curr Opin Cell Biol 2003; 15(6):763-770.
20. Schonhoff SE, Giel-Moloney M, Leiter AB. Minireview: development and differentiation of gut endocrine cells. Endocrinology 2004; 145(6):2639-2644.
21. Potten CS. Structure, function and proliferative organisation of mammalian gut. In: Potten CS, Hendry JH, eds. Radiation and Gut. New York: Elsevier, 1995:1-31.
22. Potten CS, Roberts SA, Chwalinski S, Loeffler M, Paulus U. Scoring mitotic activity in longitudinal sections of crypts of the small intestine. Cell Tissue Kinet 1988; 21(4):231-246.
23. Ijiri K, Potten CS. Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br J Cancer 1987; 55(2):113-123.
24. Potten CS, Owen G, Roberts SA. The temporal and spatial changes in cell proliferation within the irradiated crypts of the murine small intestine. Int J Radiat Biol 1990; 57(1):185-199.
25. Totafurno J, Bjerknes M, Cheng H. Variation in crypt size and its influence on the analysis of epithelial cell proliferation in the intestinal crypt. Biophys J 1988; 54(5):845-858.
26. Kellett M, Potten CS, Rew DA. A comparison of in vivo cell proliferation measurements in the intestine of mouse and man. Epithelial Cell Biol 1992; 1(4):147-155.
27. Potten CS, Kellett M, Roberts SA, Rew DA, Wilson GD. Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut 1992; 33(1):71-78.
28. Potten CS, Booth C. The role of radiation-induced and spontaneous apoptosis in the homeostasis of the gastrointestinal epithelium: a brief review. Comp Biochem Physiol B Biochem Mol Biol 1997; 118(3):473-478.
29. Potten CS. What is an apoptotic index measuring? A commentary. Br J Cancer 1996; 74(11):1743-1748.
30. Potten CS. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev 1992; 11(2):179-195.
31. Renehan AG, Bach SP, Potten CS. The relevance of apoptosis for cellular homeostasis and tumorigenesis in the intestine. Can J Gastroenterol 2001; 15(3):166-176.
32. Potten CS, Wilson JW, Booth C. Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells 1997; 15(2):82-93.
33. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 1994; 54(3):614-617.
34. Merritt AJ, Allen TD, Potten CS, Hickman JA. Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation. Oncogene 1997; 14(23):2759-2766.
35. Hickman JA. Apoptosis as a therapeutic target. In: Yarnold JR, Stratton MR, McMillan TJ, eds. Molecular Biology for Oncologists. London: Chapman & Hall, 1996:230-239.
36. Potten CS. Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine. Radiat Res 2004; 161(2):123-136.
37. Merritt AJ, Potten CS, Watson AJ, Loh DY, Nakayama K, Nakayama K, et al. Differential expression of bcl-2 in intestinal epithelia: correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci 1995; 108(Pt 6):2261-2271.
38. Watson AJ, Merritt AJ, Jones LS, Askew JN, Anderson E, Becciolini A, et al. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Br J Cancer 1996; 73(8):889-895.
39. Kitada S, Krajewska M, Zhang X, Scudiero D, Zapata JM, Wang HG, et al. Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am J Pathol 1998; 152(1):51-61.
40. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000; 60(14):3689-3695.
41. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996; 85(5):733-744.
42. Wilson JW, Pritchard DM, Hickman JA, Potten CS. Radiation-induced p53 and p21WAF-1/CIP1 expression in the murine intestinal epithelium: apoptosis and cell cycle arrest. Am J Pathol 1998; 153(3):899-909.
43. el-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995; 55(13):2910-2919.
44. Chandrasekaran C, Coopersmith CM, Gordon JI. Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators. J Biol Chem 1996; 271(45):28414-28421.
45. Kaur P, Potten CS. Cell migration velocities in the crypts of the small intestine after cytotoxic insult are not dependent on mitotic activity. Cell Tissue Kinet 1986; 19(6):601-610.
46. Qiu JM, Roberts SA, Potten CS. Cell migration in the small and large bowel shows a strong circadian rhythm. Epithelial Cell Biol 1994; 3(4):137-148.
47. Al-Dewachi HS, Wright NA, Appleton DR, Watson AJ. The effect of a single injection of hydroxyurea on cell population kinetics in the small bowel mucosa of the rat. Cell Tissue Kinet 1977; 10(3):203-213.
48. Potten CS, Loeffler M. A comprehensive model of the crypts of the small intestine of the mouse provides insight into the mechanisms of cell migration and the proliferation hierarchy. J Theor Biol 1987; 127(4):381-391.
49. Loeffler M, Birke A, Winton D, Potten C. Somatic mutation, monoclonality and stochastic models of stem cell organization in the intestinal crypt. J Theor Biol 1993; 160(4): 471-491.
50. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature 2001; 414(6859):98-104.
51. Kai T, Spradling A. An empty Drosophila stem cell niche reactivates the proliferation of ectopic cells. Proc Natl Acad Sci USA 2003; 100(8):4633-4638.
52. Plateroti M, Rubin DC, Duluc I, Singh R, Foltzer-Jourdainne C, Freund JN, et al. Subepithelial fibroblast cell lines from different levels of gut axis display regional characteristics. Am J Physiol 1998; 274(5 Pt 1):G945-G954.
53. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 1999; 277(2 Pt 1):C183-C201.
54. Potten CS, Booth C, Tudor GL, Booth D, Brady G, Hurley P et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 2003; 71(1):28-41.
55. Nakamura M, Okano H, Blendy JA, Montell C. Musashi, a neural RNA-binding protein required for Drosophila adult external sensory organ development. Neuron 1994; 13(1):67-81.
56. Moser AR, Luongo C, Gould KA, McNeley MK, Shoemaker AR, Dove WF. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 1995; 31A (7-8):1061-1064.
57. Kayahara T, Sawada M, Takaishi S, Fukui H, Seno H, Fukuzawa H, et al. Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett 2003; 535(1-3):131-135.
58. Nishimura S, Wakabayashi N, Toyoda K, Kashima K, Mitsufuji S. Expression of Musashi-1 in human normal colon crypt cells: a possible stem cell marker of human colon epithelium. Dig Dis Sci 2003; 48(8):1523-1529.
59. Withers HR, Elkind MM. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol Relat Stud Phys Chem Med 1970; 17(3):261-267.
60. Hendry JH, Roberts SA, Potten CS. The clonogen content of murine intestinal crypts: dependence on radiation dose used in its determination. Radiat Res 1992; 132(1):115-119.
61. Cai WB, Roberts SA, Potten CS. The number of clonogenic cells in crypts in three regions of murine large intestine. Int J Radiat Biol 1997; 71(5):573-579.
62. Potten CS. Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation. Nature 1977; 269(5628):518-521.
63. Potten CS, Hendry JH, Moore JV. Estimates of the number of clonogenic cells in crypts of murine small intestine. Virchows Arch B Cell Pathol Incl Mol Pathol 1987; 53(4):227-234.
64. Loeffler M, Bratke T, Paulus U, Li YQ, Potten CS. Clonality and life cycles of intestinal crypts explained by a state-dependent stochastic model of epithelial stem cell organization. J Theor Biol 1997; 186(1):41-54.
65. Mills JC, Gordon JI. The intestinal stem cell niche: there grows the neighborhood. Proc Natl Acad Sci USA 2001; 98(22):12334-12336.
66. Winton DJ, Blount MA, Ponder BA. A clonal marker induced by mutation in mouse intestinal epithelium. Nature 1988; 333(6172):463-466.
67. Bjerknes M, Cheng H. Clonal analysis of mouse intestinal epithelial progenitors. Gastroenterology 1999; 116(1):7-14.
68. Ponder BA, Schmidt GH, Wilkinson MM, Wood MJ, Monk M, Reid A. Derivation of mouse intestinal crypts from single progenitor cells. Nature 1985; 313(6004):689-691.
69. Griffiths DF, Davies SJ, Williams D, Williams GT, Williams ED. Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry. Nature 1988; 333(6172):461-463.
70. Park HS, Goodlad RA, Wright NA. Crypt fission in the small intestine and colon: a mechanism for the emergence of G6PD locus-mutated crypts after treatment with mutagens. Am J Pathol 1995; 147(5):1416-1427.
71. Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. I. Evidence from Paneth cells in the adult mouse. Am J Anat 1981; 160(1):51-63.
72. Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. II. Evidence from Paneth cells in the newborn mouse. Am J Anat 1981; 160(1):65-75.
73. Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. III. Evidence from columnar, enteroendocrine, and mucous cells in the adult mouse. Am J Anat 1981; 160(1):77-91.
74. Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. IV. Effects of resecting 30% of the small intestine. Am J Anat 1981; 160(1):93-103.
75. Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. V. Evidence for controls over orientation of boundaries between the stem-cell zone, proliferative zone, and the maturation zone. Am J Anat 1981; 160(1):105-112.
76. Jass JR, Roberton AM. Colorectal mucin histochemistry in health and disease: a critical review. Pathol Int 1994; 44(7):487-504.
77. Fuller CE, Davies RP, Williams GT, Williams ED. Crypt restricted heterogeneity of goblet cell mucus glycoprotein in histologically normal human colonic mucosa: a potential marker of somatic mutation. Br J Cancer 1990; 61(3):382-384.
78. Campbell F, Williams GT, Appleton MA, Dixon MF, Harris M, Williams ED. Postirradiation somatic mutation and clonal stabilisation time in the human colon. Gut 1996; 39(4):569-573.
79. Novelli MR, Williamson JA, Tomlinson IP, Elia G, Hodgson SV, Talbot IC, et al. Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science 1996; 272(5265): 1187-1190.
80. Novelli M, Cossu A, Oukrif D, Quaglia A, Lakhani S, Poulsom R, et al. X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. Proc Natl Acad Sci USA 2003; 100(6):3311-3314.
81. Brierley EJ, Johnson MA, Lightowlers RN, James OF, Turnbull DM. Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol 1998; 43(2):217-223.
82. Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 1999; 286(5440):774-779.
83. Carew JS, Huang P. Mitochondrial defects in cancer. Mol Cancer 2002; 1(1):9.
84. Taylor RW, Barron MJ, Borthwick GM, Gospel A, Chinnery PF, Samuels DC et al. Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest 2003; 112(9):1351-1360.
85. Pearse AG, Takor TT. Neuroendocrine embryology and the APUD concept. Clin Endocrinol (Oxf) 1976; 5(suppl):229S-244S.
86. Le Douarin N, Le Lievre C. Demonstration of neural origin of calcitonin cells of ultimobranchial body of chick embryo. CR Acad Sci Hebd Seances Acad Sci D 1970; 270(23):2857-2860.
87. Holzer H. Cell lineages, stem cells and the “quantal cell cycle concept”. In: Potten CS, Lord BI, Schofield R, eds. Stem Cells and Tissue Homeostasis. Cambridge: Cambridge University Press, 1978:1-27.
88. Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am J Anat 1974; 141(4):537-561.
89. Potten CS, Schofield R, Lajtha LG. A comparison of cell replacement in bone marrow, testis and three regions of surface epithelium. Biochim Biophys Acta 1979; 560(2):281-299.
90. Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. I. Identification of proliferative cell types and pinpointing of the stem cell. Anat Rec 1993; 236(2):259-279.
91. Kirkland SC. Clonal origin of columnar, mucous, and endocrine cell lineages in human colorectal epithelium. Cancer 1988; 61(7):1359-1363.
92. Cox WF Jr, Pierce GB. The endodermal origin of the endocrine cells of an adenocarcinoma of the colon of the rat. Cancer 1982; 50(8):1530-1538.
93. Henderson K, Kirkland SC. Multilineage differentiation of cloned HRA-19 cells in serumfree medium: a model of human colorectal epithelial differentiation. Differentiation 1996; 60(4):259-268.
94. Wong WM, Wright NA. Cell proliferation in gastrointestinal mucosa. J Clin Pathol 1999; 52(5):321-333.
95. St Clair WH, Osborne JW. Crypt fission and crypt number in the small and large bowel of postnatal rats. Cell Tissue Kinet 1985; 18(3):255-262.
96. Maskens AP, Dujardin-Loits RM. Kinetics of tissue proliferation in colorectal mucosa during postnatal growth. Cell Tissue Kinet 1981; 14(5):467-477.
97. Cairnie AB, Millen BH. Fission of crypts in the small intestine of the irradiated mouse. Cell Tissue Kinet 1975; 8(2):189-196.
98. Wright NA, Al-Nafussi A. The kinetics of villus cell populations in the mouse small intestine. II. Studies on growth control after death of proliferative cells induced by cytosine arabinoside, with special reference to negative feedback mechanisms. Cell Tissue Kinet 1982; 15(6): 611-621.
99. Totafurno J, Bjerknes M, Cheng H. The crypt cycle: crypt and villus production in the adult intestinal epithelium. Biophys J 1987; 52(2):279-294.
100. Bjerknes M. The crypt cycle and the asymptotic dynamics of the proportion of differently sized mutant crypt clones in the mouse intestine. Proc R Soc Lond B Biol Sci 1995; 260(1357):1-6.
101. Bjerknes M. Expansion of mutant stem cell populations in the human colon. J Theor Biol 1996; 178(4):381-385.
102. Kim KM, Shibata D. Tracing ancestry with methylation patterns: most crypts appear distantly related in normal adult human colon. BMC Gastroenterol 2004; 4(1):8.
103. Potten CS, Hume WJ, Reid P, Cairns J. The segregation of DNA in epithelial stem cells. Cell 1978; 15(3):899-906.
104. Cairns J. Mutation selection and the natural history of cancer. Nature 1975; 255(5505): 197-200.
105. Potten CS, Owen G, Booth D. Intestinal stem cells protect their genome by selective segregation of template DNA strands. J Cell Sci 2002; 115(Pt 11):2381-2388.
106. Merok JR, Lansita JA, Tunstead JR, Sherley JL. Cosegregation of chromosomes containing immortal DNA strands in cells that cycle with asymmetric stem cell kinetics. Cancer Res 2002; 62(23):6791-6795.
107. Smith GH. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 2005; 132(4):681-687.
108. Cairns J. Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc Natl Acad Sci USA 2002; 99(16):10567-10570.
109. Heddle JA, Cosentino L, Dawod G, Swiger RR, Paashuis-Lew Y. Why do stem cells exist? Environ Mol Mutagen 1996; 28(4):334-341.
110. Schmidt GH, Winton DJ, Ponder BA. Development of the pattern of cell renewal in the crypt-villus unit of chimaeric mouse small intestine. Development 1988; 103(4):785-790.
111. Yatabe Y, Tavare S, Shibata D. Investigating stem cells in human colon by using methylation patterns. Proc Natl Acad Sci USA 2001; 98(19):10839-10844.
112. Vidrich A, Buzan JM, Cohn SM. Intestinal stem cells and mucosal gut development. Curr Opin Gastroenterol 2003; 19(6):583-590.
113. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, et al. Control of endodermal endocrine development by Hes-1. Nat Genet 2000; 24(1):36-44.
114. Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001; 294(5549):2155-2158.
115. Stappenbeck TS, Gordon JI. Rac1 mutations produce aberrant epithelial differentiation in the developing and adult mouse small intestine. Development 2000; 127(12):2629-2642.
116. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998; 19(4):379-383.
117. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103(2):311-320.
118. Bienz M. APC. Curr Biol 2003; 13(6):R215-R216.
119. Karim R, Tse G, Putti T, Scolyer R, Lee S. The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004; 36(2):120-128.
120. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005; 434(7035): 843-850.
121. Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005; 307(5717):1904-1909.
122. Pinto D, Clevers H. Wnt, stem cells and cancer in the intestine. Biol Cell 2005; 97(3): 185-196.
123. Sancho E, Batlle E, Clevers H. Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 2004; 20:695-723.
124. Booth C, Brady G, Potten CS. Crowd control in the crypt. Nat Med 2002; 8(12):1360-1361.
125. Wong MH, Stappenbeck TS, Gordon JI. Living and commuting in intestinal crypts. Gastroenterology 1999; 116(1):208-210.
126. Staal FJ, van Noort M, Strous GJ, Clevers HC. Wnt signals are transmitted through Nterminally dephosphorylated beta-catenin. EMBO Rep 2002; 3(1):63-68.
127. de Lau W, Clevers H. LEF1 turns over a new leaf. Nat Genet 2001; 28(1):3-4.
128. Brantjes H, Barker N, van Es J, Clevers H. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling. Biol Chem 2002; 383(2):255-261.
129. Pelengaris S, Khan M, Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002; 2(10):764-776.
130. Issack PS, Ziff EB. Altered expression of helix-loop-helix transcriptional regulators and cyclin D1 in Wnt-1-transformed PC12 cells. Cell Growth Differ 1998; 9(10):837-845.
131. Blache P, van de Wetering M, Duluc I, Domon C, Berta P, Freund JN, et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol 2004; 166(1):37-47.
132. van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H. Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 2002; 277(20):17901-17905.
133. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, et al. The betacatenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002; 111(2):241-250.
134. Kim KM, Shibata D. Methylation reveals a niche: stem cell succession in human colon crypts. Oncogene 2002; 21(35):5441-5449.
135. Heinen CD, Goss KH, Cornelius JR, Babcock GF, Knudsen ES, Kowalik T, et al. The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway. Gastroenterology 2002; 123(3):751-763.
136. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 1998; 391(6665):357-362.
137. Lickert H, Kispert A, Kutsch S, Kemler R. Expression patterns of Wnt genes in mouse gut development. Mech Dev 2001; 105(1-2):181-184.
138. McBride HJ, Fatke B, Fraser SE. Wnt signaling components in the chicken intestinal tract. Dev Biol 2003; 256(1):18-33.
139. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 2002; 111(2):251-263.
140. Frisen J, Holmberg J, Barbacid M. Ephrins and their Eph receptors: multitalented directors of embryonic development. EMBO J 1999; 18(19):5159-5165.
141. Stephenson SA, Slomka S, Douglas EL, Hewett PJ, Hardingham JE. Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer. BMC Mol Biol 2001; 2(1):15.
142. Jenny M, Uhl C, Roche C, Duluc I, Guillermin V, Guillemot F, et al. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J 2002; 21(23):6338-6347.
143. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 2002; 417(6889):664-667.
144. Zheng JL, Shou J, Guillemot F, Kageyama R, Gao WQ. Hes1 is a negative regulator of inner ear hair cell differentiation. Development 2000; 127(21):4551-4560.
145. Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, Yang VW, et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 2002; 129(11):2619-2628.
146. Ng AY, Waring P, Ristevski S, Wang C, Wilson T, Pritchard M, et al. Inactivation of the transcription factor Elf3 in mice results in dysmorphogenesis and altered differentiation of intestinal epithelium. Gastroenterology 2002; 122(5):1455-1466.
147. Zhu L, Skoultchi AI. Coordinating cell proliferation and differentiation. Curr Opin Genet Dev 2001; 11(1):91-97.
148. Deschenes C, Vezina A, Beaulieu JF, Rivard N. Role of p27(Kip1) in human intestinal cell differentiation. Gastroenterology 2001; 120(2):423-438.
149. Quaroni A, Tian JQ, Seth P, Ap Rhys C. p27(Kip1) is an inducer of intestinal epithelial cell differentiation. Am J Physiol Cell Physiol 2000; 279(4):C1045-C1057.
150. Yang W, Velcich A, Mariadason J, Nicholas C, Corner G, Houston M, et al. p21(WAF1/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo. Cancer Res 2001; 61(16):6297-6302.
151. Wong MH, Huelsken J, Birchmeier W, Gordon JI. Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkühn is perturbed by stimulation of Lef-1/beta-catenin signaling. J Biol Chem 2002; 277(18):15843-15850.
152. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3(8):917-921.
153. Ambrosini G, Adida C, Sirugo G, Altieri DC. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 1998; 273(18):11177-11182.
154. Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri DC. Survivin and molecular pathogenesis of colorectal cancer. Lancet 2003; 362(9379):205-209.
155. Nohe A, Keating E, Knaus P, Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004; 16(3):291-299.
156. Hardwick JC, van den Brink GR, Bleuming SA, Ballester I, van den Brande JM, Keller JJ, et al. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 2004; 126(1):111-121.
157. Sayed MG, Ahmed AF, Ringold JR, Anderson ME, Bair JL, Mitros FA, et al. Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol 2002; 9(9):901-906.
158. He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 2004; 36(10):1117-1121.
159. Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002; 70(4):829-844.
160. Tian Q, He XC, Hood L, Li L. Bridging the BMP and Wnt pathways by PI3 kinase/Akt and 14-3-3zeta. Cell Cycle 2005; 4(2):215-216.
161. Wilson JW, Nostro MC, Balzi M, Faraoni P, Cianchi F, Becciolini A, et al. Bcl-w expression in colorectal adenocarcinoma. Br J Cancer 2000; 82(1):178-185.
162. Potten CS, Owen G, Hewitt D, Chadwick CA, Hendry H, Lord BI, et al. Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors. Gut 1995; 36(6):864-873.
163. Booth D, Haley JD, Bruskin AM, Potten CS. Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling. Int J Cancer 2000; 86(1):53-59.
164. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, et al. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996; 86(4):531-542.
165. Lickert H, Domon C, Huls G, Wehrle C, Duluc I, Clevers H, et al. Wnt/(beta)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine. Development 2000; 127(17):3805-3813.
166. Walters JR. Cell and molecular biology of the small intestine: new insights into differentiation, growth and repair. Curr Opin Gastroenterol 2004; 20(2):70-76.
167. Kaestner KH, Bleckmann SC, Monaghan AP, Schlondorff J, Mincheva A, Lichter P, et al. Clustered arrangement of winged helix genes fkh-6 and MFH-1: possible implications for mesoderm development. Development 1996; 122(6):1751-1758.
168. Kaestner KH, Knochel W, Martinez DE. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 2000; 14(2):142-146.
169. Kaestner KH, Silberg DG, Traber PG, Schutz G. The mesenchymal winged helix transcription factor Fkh6 is required for the control of gastrointestinal proliferation and differentiation. Genes Dev 1997; 11(12):1583-1595.
170. Hay T, Patrick T, Winton D, Sansom OJ, Clarke AR. Brca2 deficiency in the murine small intestine sensitizes to p53-dependent apoptosis and leads to the spontaneous deletion of stem cells. Oncogene 2005; 28:28.
171. Madison BB, Braunstein K, Kuizon E, Portman K, Qiao XT, Gumucio DL. Epithelial hedgehog signals pattern the intestinal crypt-villus axis. Development 2005; 132(2): 279-289.
172. Mills JC, Andersson N, Hong CV, Stappenbeck TS, Gordon JI. Molecular characterization of mouse gastric epithelial progenitor cells. Proc Natl Acad Sci USA 2002; 99(23):14819-14824.
173. Stappenbeck TS, Mills JC, Gordon JI. Molecular features of adult mouse small intestinal epithelial progenitors. Proc Natl Acad Sci USA 2003; 100(3):1004-1009.
174. Mariadason JM, Nicholas C, L’Italien KE, Zhuang M, Smartt HJ, Heerdt BG, et al. Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis. Gastroenterology 2005; 128(4):1081-1088.
175. Hill MJ, Morson BC, Bussey HJ. Aetiology of adenoma—carcinoma sequence in large bowel. Lancet 1978; 1(8058):245-247.
176. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319(9):525-532.
177. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61(5):759-767.
178. Kinzler KW, Vogelstein B. Cancer-susceptibility genes: gatekeepers and caretakers. Nature 1997; 386(6627):761-763.
179. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10(8):789-799.
180. Fodde R. The APC gene in colorectal cancer. Eur J Cancer 2002; 38(7):867-871.
181. Lamlum H, Papadopoulou A, Ilyas M, Rowan A, Gillet C, Hanby A, et al. APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci USA 2000; 97(5):2225-2228.
182. Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 2004; 23(1-2):29-39.
183. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348(10): 919-932.
184. Lipton L, Tomlinson I. The multiple colorectal adenoma phenotype and MYH, a base excision repair gene. Clin Gastroenterol Hepatol 2004; 2(8):633-638.
185. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001; 1(1):55-67.
186. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih IM, Vogelstein B, et al. The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 2002; 99(25):16226-16231.
187. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275(5307):1787-1790.
188. Hao X, Frayling IM, Willcocks TC, Han W, Tomlinson IP, Pignatelli MN, et al. Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis. Virchows Arch 2002; 440(4):362-366.
189. Brabletz T, Herrmann K, Jung A, Faller G, Kirchner T. Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 2000; 156(3):865-870.
190. Shih IM, Wang TL, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, et al. Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci 2001; 98(5):2640-2645.
191. Bird RP, McLellan EA, Bruce WR. Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv 1989; 8(1):189-200.
192. Roncucci L, Pedroni M, Vaccina F, Benatti P, Marzona L, De Pol A. Aberrant crypt foci in colorectal carcinogenesis: cell and crypt dynamics. Cell Prolif 2000; 33(1):1-18.
193. Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 2000; 26(2):146-147.
194. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000; 24(3):245-250.
195. Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, Bell J, et al. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson’s ‘two-hit’ hypothesis. Nat Med 1999; 5(9):1071-1075.
196. Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP, et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 2004; 18(12):1385-1390.
197. Sieber OM, Heinimann K, Gorman P, Lamlum H, Crabtree M, Simpson CA, et al. Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. Proc Natl Acad Sci USA 2002; 99(26):16910-16915.
198. Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, Gaspar C, et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 2001; 3(4): 433-438.
199. Hassan AB, Howell JA. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice. Cancer Res 2000; 60(4):1070-1076.
200. Sakatani T, Kaneda A, Iacobuzio-Donahue CA, Carter MG, de Boom Witzel S, Okano H, et al. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 2005; 307(5717):1976-1978.
201. Wong WM, Garcia SB, Wright NA. Origins and morphogenesis of colorectal neoplasms. Apmis 1999; 107(6):535-544.
202. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987; 238(4824):193-197.
203. Fialkow PJ. Clonal origin of human tumors. Biochim Biophys Acta 1976; 458(3):283-321.
204. Garcia SB, Novelli M, Wright NA. The clonal origin and clonal evolution of epithelial tumours. Int J Exp Pathol 2000; 81(2):89-116.
205. Brickman JM, Burdon TG. Pluripotency and tumorigenicity. Nat Genet 2002; 32(4): 557-558.
206. Kielman MF, Rindapaa M, Gaspar C, Van Poppel N, Breukel C, Van Leeuwen S, et al. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet 2002; 32(4):594-605.
207. Gaspar C, Fodde R. APC dosage effects in tumorigenesis and stem cell differentiation. Int J Dev Biol 2004; 48(5-6):377-386.
208. Merritt AJ, Gould KA, Dove WF. Polyclonal structure of intestinal adenomas in ApcMin/+ mice with concomitant loss of Apc+ from all tumor lineages. Proc Natl Acad Sci USA 1997; 94(25):13927-13931.
209. Playford RJ. Tales from the human crypt—intestinal stem cell repertoire and the origins of human cancer. J Pathol 1998; 185(2):119-122.
210. Deschner EE. Early proliferative changes in gastrointestinal neoplasia. Am J Gastroenterol 1982; 77(4):207-211.
211. Itzkowitz SH, Kim YS. Polyp and benign neoplasms of the colon. In: Sleisenger MH, Fordtran JS, Scharschmidt BF, Feldman M, eds. Gastrointestinal Disease: Pathophysiology/Diagnosis/Management. Philadelphia: Saunders WB, 1993:1402-1430.
212. Risio M. Cell proliferation in colorectal tumor progression: an immunohistochemical approach to intermediate biomarkers. J Cell Biochem Suppl 1992; 16g:79-87.
213. Polyak K, Hamilton SR, Vogelstein B, Kinzler KW. Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol 1996; 149(2):381-387.
214. Sinicrope FA, Roddey G, Lemoine M, Ruan S, Stephens LC, Frazier ML, et al. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers. Clin Cancer Res 1998; 4(5):1251-1261.
215. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995; 55(2):237-241.
216. Sinicrope FA, Roddey G, McDonnell TJ, Shen Y, Cleary KR, Stephens LC. Increased apoptosis accompanies neoplastic development in the human colorectum. Clin Cancer Res 1996; 2(12):1999-2006.
217. Maskens AP. Histogenesis of adenomatous polyps in the human large intestine. Gastroenterology 1979; 77(6):1245-1251.
218. Nigro ND, Bull AW. Experimental intestinal carcinogenesis. Br J Surg 1985; 72(suppl): S36-S37.
219. Moss SF, Liu TC, Petrotos A, Hsu TM, Gold LI, Holt PR. Inward growth of colonic adenomatous polyps. Gastroenterology 1996; 111(6):1425-1432.
220. Shiff SJ, Rigas B. Colon adenomatous polyps—do they grow inward? Lancet 1997; 349(9069):1853-1854.
221. Lamprecht SA, Lipkin M. Migrating colonic crypt epithelial cells: primary targets for transformation. Carcinogenesis 2002; 23(11):1777-1780.
222. Nakamura S, Kino I. Morphogenesis of minute adenomas in familial polyposis coli. J Natl Cancer Inst 1984; 73(1):41-49.
223. Woda BA, Forde K, Lane N. A unicryptal colonic adenoma, the smallest colonic neoplasm yet observed in a non-polyposis individual. Am J Clin Pathol 1977; 68(5):631-632.
224. Campbell F, Geraghty JM, Appleton MA, Williams ED, Williams GT. Increased stem cell somatic mutation in the non-neoplastic colorectal mucosa of patients with familial adenomatous polyposis. Hum Pathol 1998; 29(12):1531-1535.
225. Chang WW, Whitener CJ. Histogenesis of tubular adenomas in hereditary colonic adenomatous polyposis. Arch Pathol Lab Med 1989; 113(9):1042-1049.
226. Wasan HS, Park HS, Liu KC, Mandir NK, Winnett A, Sasieni P, et al. APC in the regulation of intestinal crypt fission. J Pathol 1998; 185(3):246-255.
227. Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV, et al. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 1994; 54(21):5527-5530.
228. Fujimitsu Y, Nakanishi H, Inada K, Yamachika T, Ichinose M, Fukami H, et al. Development of aberrant crypt foci involves a fission mechanism as revealed by isolation of aberrant crypts. Jpn J Cancer Res 1996; 87(12):1199-1203.
229. Siu IM, Robinson DR, Schwartz S, Kung HJ, Pretlow TG, Petersen RB, et al. The identification of monoclonality in human aberrant crypt foci. Cancer Res 1999; 59(1):63-66.
230. Araki K, Ogata T, Kobayashi M, Yatani R. A morphological study on the histogenesis of human colorectal hyperplastic polyps. Gastroenterology 1995; 109(5):1468-1474.
231. Wright NA, Poulsom R. Top-down or bottom-up? Competing management structures in the morphogenesis of colorectal neoplasms. Gut 2002; 51(3):306-308.
232. Boman BM, Fields JZ, Bonham Carter O, Runquist OA. Computer modeling implicates stem cell overproduction in colon cancer initiation. Cancer Res 2001; 61(23):8408-8411.
233. Kim KM, Calabrese P, Tavare S, Shibata D. Enhanced stem cell survival in familial adenomatous polyposis. Am J Pathol 2004; 164(4):1369-1377.
234. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, Boman BM. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 2001; 61(24):8664-8667.
235. Garcia SB, Park HS, Novelli M, Wright NA. Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol 1999; 187(1):61-81.
236. Preston SL, Wong WM, Chan AO, Poulsom R, Jeffery R, Goodlad RA, et al. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res 2003; 63(13):3819-3825.
237. Wong WM, Mandir N, Goodlad RA, Wong BC, Garcia SB, Lam SK, et al. Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut 2002; 50(2):212-217.
238. Renehan AG, Booth C, Potten CS. What is apoptosis, and why is it important? BMJ 2001; 322(7301):1536-1538.
239. Yang WC, Mathew J, Velcich A, Edelmann W, Kucherlapati R, Lipkin M, et al. Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res 2001; 61(2):565-569.
240. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414(6859):105-111.
241. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, et al. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 2004; 4(8):653-671.
242. Dihlmann S, von Knebel Doeberitz M. Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int J Cancer 2005; 113(4):515-524.
243. Potten CS, Booth C, Hargreaves D. The small intestine as a model for evaluating adult tissue stem cell drug targets. Cell Prolif 2003; 36(3):115-129.
244. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA 2003; 100(suppl 1): 11917-11923.
245. Kawaguchi AL, Dunn JC, Fonkalsrud EW. In vivo growth of transplanted genetically altered intestinal stem cells. J Pediatr Surg 1998; 33(4):559-563.
246. Wang G, Bunnell BA, Painter RG, Quiniones BC, Tom S, Lanson NA Jr, et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci USA 2005; 102(1):186-191.
247. Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 1998; 4(11): 1276-1280.
248. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003; 299(5613):1753-1755.
249. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, et al. Genes expressed in human tumor endothelium. Science 2000; 289(5482):1197-1202.
250. Renehan AG, Painter JE, O’Halloran D, Atkin WS, Potten CS, O’Dwyer ST, et al. Circulating insulin-like growth factor II and colorectal adenomas. J Clin Endocrinol Metab 2000; 85(9):3402-3408.
251. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105(3):369-377.
252. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418(6893):41-49.
253. Matsumoto T, Okamoto R, Yajima T, Mori T, Okamoto S, Ikeda Y, et al. Increase of bone marrow-derived secretory lineage epithelial cells during regeneration in the human intestine. Gastroenterology 2005; 128(7):1851-1867.
254. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306(5701):1568-1571.
255. Marx J. Medicine. Bone marrow cells: the source of gastric cancer? Science 2004; 306(5701):1455-1457.